For an older adult with neuro‑psychiatric manifestations (cognitive decline, memory loss, gait disturbance, peripheral neuropathy, mood or psychotic symptoms), which vitamin B12 preparation is recommended, and which preparation is appropriate for an older adult without neurological or psychiatric symptoms?

Vitamin B12 Preparation Selection Based on Neuropsychiatric Symptoms

For older adults with neuropsychiatric manifestations (cognitive decline, memory loss, gait disturbance, peripheral neuropathy, mood or psychotic symptoms), hydroxocobalamin 1 mg intramuscularly on alternate days until neurological improvement plateaus is the definitive treatment, followed by maintenance dosing of 1 mg intramuscularly every 2 months for life. 1

Patients WITH Neurological or Psychiatric Symptoms

Initial Intensive Treatment Phase

• Administer hydroxocobalamin 1 mg intramuscularly on alternate days and continue this aggressive schedule until no further neurological improvement is observed, which typically requires several weeks to months. 1
• This intensive regimen is mandatory because neurological symptoms—including cognitive difficulties, memory impairment, peripheral neuropathy, gait ataxia, paresthesias, glossitis, depression, anxiety, psychosis, and delirium—can become irreversible if treatment is delayed or inadequate. 1, 2, 3, 4
• Neurological deficits often present before hematologic abnormalities develop; approximately one-third of patients with B12 deficiency show no macrocytic anemia, making clinical suspicion paramount. 5, 2

Maintenance Therapy

• After neurological recovery plateaus, transition to hydroxocobalamin 1 mg intramuscularly every 2 months for life. 1
• Some patients may require monthly dosing (1000 mcg IM monthly) to better meet metabolic requirements, particularly those with persistent symptoms despite standard dosing, post-bariatric surgery patients, or patients with extensive ileal disease. 1

Critical Safety Precaution

• Never administer folic acid before correcting vitamin B12 deficiency; folic acid can mask megaloblastic anemia while allowing irreversible subacute combined degeneration of the spinal cord to progress. 1, 6
• Only after successful B12 repletion should folic acid 5 mg daily be added if concurrent folate deficiency is documented. 1

---

Patients WITHOUT Neurological or Psychiatric Symptoms

Initial Loading Phase

• Give hydroxocobalamin 1 mg intramuscularly three times weekly for 2 weeks. 1
• This schedule corrects biochemical deficiency while avoiding overtreatment in asymptomatic individuals. 1

Maintenance Therapy

• Continue with hydroxocobalamin 1 mg intramuscularly every 2–3 months for life. 1
• This lifelong maintenance is necessary because the underlying cause (typically malabsorption from pernicious anemia, ileal resection, bariatric surgery, or atrophic gastritis) is expected to persist. 1

---

Formulation Selection: Hydroxocobalamin vs. Cyanocobalamin vs. Methylcobalamin

Preferred Injectable Form

• Hydroxocobalamin is the guideline-recommended first-line injectable for adult vitamin B12 deficiency, with dosing of 1 mg intramuscularly every 2–3 months for maintenance therapy. 1
• Hydroxocobalamin has superior tissue retention compared to cyanocobalamin and is the form specified in all major guideline dosing protocols. 1

Renal Dysfunction Considerations

• In patients with renal dysfunction (estimated GFR < 50 mL/min), methylcobalamin or hydroxocobalamin should be chosen over cyanocobalamin because cyanocobalamin generates cyanide metabolites that require renal clearance. 1
• In patients with diabetic nephropathy, cyanocobalamin doubled the risk of cardiovascular events (hazard ratio ≈ 2.0) compared with placebo. 1
• Cyanocobalamin must be avoided in individuals with impaired renal function due to accumulation of cyanide-derived thiocyanate and consequent cardiovascular risk. 1

Practical Dosing Table

Clinical Scenario	Preferred Form	Initial Dosing	Maintenance Dosing
With neuropsychiatric symptoms	Hydroxocobalamin	1 mg IM alternate days until improvement plateaus	1 mg IM every 2 months for life
Without neuropsychiatric symptoms	Hydroxocobalamin	1 mg IM three times weekly × 2 weeks	1 mg IM every 2–3 months for life
Renal dysfunction (GFR < 50)	Hydroxocobalamin or Methylcobalamin	Follow hydroxocobalamin protocol	1 mg IM every 2–3 months for life
Post-bariatric surgery	Hydroxocobalamin	1 mg IM three times weekly × 2 weeks	1 mg IM every 3 months for life

---

Special Populations Requiring Prophylactic Treatment

Post-Bariatric Surgery

• Patients who have undergone bariatric surgery should receive routine prophylactic hydroxocobalamin 1000 µg intramuscularly every 3 months indefinitely, irrespective of documented deficiency, to prevent malabsorption-related B12 loss. 1
• Alternative regimens include oral vitamin B12 1000–2000 µg daily or a single intramuscular dose of 1000 µg each month. 1

Ileal Resection or Crohn's Disease

• Patients with ileal resection >20 cm should receive prophylactic hydroxocobalamin 1000 mcg IM monthly for life, even without documented deficiency. 1, 6
• Patients with Crohn's disease involving >30–60 cm of ileum are at risk even without resection and require annual screening and prophylactic supplementation. 1, 6

---

Monitoring Strategy

Initial Monitoring (First Year)

• Recheck serum B12 levels at 3 months, 6 months, and 12 months after initiating supplementation. 1
• At each monitoring point, assess:
  • Serum B12 levels as the primary marker 1
  • Complete blood count to evaluate for resolution of megaloblastic anemia 1
  • Methylmalonic acid (MMA) if B12 levels remain borderline or symptoms persist (target <271 nmol/L) 1, 6
  • Homocysteine as an additional functional marker (target <10 μmol/L) 1

Long-Term Monitoring

• Once B12 levels stabilize within normal range for two consecutive checks (typically by 6–12 months), transition to annual monitoring to detect any recurrence. 1
• For post-bariatric surgery patients planning pregnancy, B12 levels should be checked every 3 months. 1

Neurological Symptom Monitoring

• Clinical monitoring of neurological symptoms is more important than laboratory values in patients with neurological involvement. 1
• Monitor for improvement in pain, paresthesias, numbness, motor weakness, cognitive difficulties, and gait disturbances. 1
• Pain and paresthesias often improve before motor symptoms. 1

---

Common Pitfalls to Avoid

Do Not Rely Solely on Serum B12 Levels

• Standard serum B12 testing misses functional deficiency in up to 50% of cases; in the Framingham Study, 12% had low serum B12, but an additional 50% had elevated methylmalonic acid indicating metabolic deficiency despite "normal" serum levels. 6
• In elderly patients (>60 years), 18.1% have metabolic B12 deficiency despite normal or even elevated serum B12 levels. 6, 5

Do Not Stop Treatment After Symptoms Improve

• Stopping injections after symptoms improve can lead to irreversible peripheral neuropathy from B12 deficiency. 1
• Patients with permanent causes of B12 deficiency (pernicious anemia, ileal resection >20 cm, post-bariatric surgery) require lifelong intramuscular vitamin B12 injections. 1

Do Not Give Folic Acid First

• Administering folic acid before repleting vitamin B12 can mask megaloblastic anemia while permitting ongoing neuro-degeneration (subacute combined degeneration) to progress unchecked. 1, 6

Do Not Delay Treatment in Confirmed Deficiency

• When serum B12 is <180 pg/mL in the presence of compatible symptoms, treatment should be started immediately without awaiting confirmatory testing. 1
• Intramuscular hydroxocobalamin or cyanocobalamin 1000 µg should be administered without delay in patients with confirmed deficiency; waiting for MMA, homocysteine, or intrinsic-factor antibody results is not recommended. 1

---

Route of Administration: When Intramuscular Injection Is Mandatory

• Intramuscular therapy is required for patients with severe neurological involvement, because it provides faster clinical improvement than oral dosing. 1
• Intramuscular therapy is required after bariatric surgery (especially Roux-en-Y gastric bypass or biliopancreatic diversion) due to impaired intrinsic factor–mediated absorption. 1
• Intramuscular therapy is required for patients needing rapid correction of B12 levels (e.g., acute neurologic decline). 1
• The definitive parenteral treatment is intramuscular (or deep subcutaneous) injection of hydroxocobalamin 1000 µg; intravenous administration is not recommended in current guidelines. 1

---

Key Neuropsychiatric Manifestations to Recognize

• Vitamin B12 deficiency causes cognitive difficulties, memory impairment, peripheral neuropathy, gait ataxia, paresthesias, glossitis, depression, anxiety, psychosis, dementia, and delirium. 1, 2, 3, 4
• Subacute combined degeneration (SCD) of the spinal cord is characterized by symmetric dysesthesia, disturbance of position sense, and spastic paraparesis or tetraparesis. 4
• Neuropsychiatric symptoms may precede hematologic signs and can occur even with normal or elevated serum B12 levels. 2, 3, 4
• The whole range of neuropsychiatric disorders with vitamin B12 deficiency includes apathy, agitation, impaired concentration, insomnia, persecutory delusions, auditory and visual hallucinations, and disorganized thought-process. 3